Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion type Assertion NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_head.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion description "[In mixed populations of NIS-MSCs and hepatocellular cancer (HCC) cells, clonogenic assays showed a 55% reduction of HCC cell survival after (131)I application.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_provenance.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion evidence source_evidence_literature NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_provenance.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion SIO_000772 21587211 NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_provenance.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion wasDerivedFrom befree-20140225 NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_provenance.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion wasGeneratedBy ECO_0000203 NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_provenance.